Investors brace for what’s next as U.S.-Iran war stretches into second week

Only one question is on people’s minds: How long will the U.S.-Israel war with Iran last?
Find safety and income in these tax-exempt bonds as the Iran war stirs up the market

Rates on municipal bonds moved higher this week, which many see as an opportunity to lock in yields and stabilize portfolios.
Robinhood’s venture fund, which gives investors access to private companies, tanks 11% on first day

Robinhood’s Venture Fund I plunged 11% in its debut on the New York Stock Exchange on Friday, casting doubt on investors’ appetite for riskier investment.
Amazon says customers can keep using Anthropic’s Claude on its cloud for non-defense workloads

Amazon joined Microsoft and Google in continue to offer Anthropic’s Claude AI technology to customers after the Pentagon deemed it a “supply chain risk.”
Vast wraps $500 million funding round as company vies for NASA space station contract

Vast Space is betting on a “leapfrog strategy” to land a phase two NASA award for the International Space Station.
The charts are showing oil may have overextended higher, says Carter Worth

Carter Worth looks through the charts in oil after a wild week.
Google joins Microsoft in telling users Anthropic is still available outside defense projects

Cloud vendors are letting customers know that Anthropic’s popular AI tools can still be accessed after the Department of Defense blacklisted the company.
Greg Abel makes his first big moves as Berkshire Hathaway CEO. Is it time to buy back in?

While the steps were viewed as positive signals, analysts said they are unlikely to materially alter their outlook for the shares.
Fed Governor Miran says job losses in February add to the case for more interest rate cuts

Miran said in a CNBC interview that the Fed should be focusing more on supporting the labor market than worrying about inflation.
Market turmoil is hitting most traditional safe havens. UBS says this is the place to hide

Pharmaceutical stocks like Eli Lilly and Merck are good places to help investors ride out a recent rise in geopolitical turmoil, according to UBS.